ATE249227T1 - Verwendung von fucosilierten sialilierten n- acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion - Google Patents
Verwendung von fucosilierten sialilierten n- acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsionInfo
- Publication number
- ATE249227T1 ATE249227T1 AT00921217T AT00921217T ATE249227T1 AT E249227 T1 ATE249227 T1 AT E249227T1 AT 00921217 T AT00921217 T AT 00921217T AT 00921217 T AT00921217 T AT 00921217T AT E249227 T1 ATE249227 T1 AT E249227T1
- Authority
- AT
- Austria
- Prior art keywords
- lactosamine
- sialyl
- acetyl
- fucosilated
- sialilated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9901007A SE9901007D0 (sv) | 1999-03-19 | 1999-03-19 | Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence |
PCT/SE2000/000514 WO2000056343A1 (en) | 1999-03-19 | 2000-03-16 | Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE249227T1 true ATE249227T1 (de) | 2003-09-15 |
Family
ID=20414923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00921217T ATE249227T1 (de) | 1999-03-19 | 2000-03-16 | Verwendung von fucosilierten sialilierten n- acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1169044B1 (de) |
JP (1) | JP2002539266A (de) |
AT (1) | ATE249227T1 (de) |
AU (1) | AU4155700A (de) |
DE (1) | DE60005164D1 (de) |
SE (1) | SE9901007D0 (de) |
WO (1) | WO2000056343A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002066502A1 (en) * | 2001-02-21 | 2002-08-29 | Boren Thomas | Helicobacter pylori sialic acid binding adhesin, saba and saba - gene |
ATE429233T1 (de) * | 2001-06-29 | 2009-05-15 | Glykos Finland Oy | Verwendung mindestens einer glycoinhibitor- substanz gegen infektionskrankheiten |
FI20011403A (fi) * | 2001-06-29 | 2002-12-30 | Carbion Oy | Menetelmä ja koostumukset vatsan sairauksien hoitoon |
JP2005532793A (ja) * | 2002-04-22 | 2005-11-04 | レコファーマ アーベー | 微生物付着を阻害するための融合ポリペプチドおよび方法 |
FI20021989A0 (fi) * | 2002-11-06 | 2002-11-06 | Halina Miller-Podraza | Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö |
EP2692740A1 (de) * | 2012-07-30 | 2014-02-05 | Le Centre National De La Recherche Scientifique | Glycanzusammensetzungen, Verfahren zu deren Herstellung und deren Verwendungen als Arzneimittel |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK76193D0 (da) * | 1993-06-25 | 1993-06-25 | Astra Ab | Kulhydratderivater |
WO1995023605A1 (en) * | 1994-03-02 | 1995-09-08 | Neose Pharmaceuticals, Inc. | Method for treating and inhibiting gastric and duodenal ulcers |
-
1999
- 1999-03-19 SE SE9901007A patent/SE9901007D0/xx unknown
-
2000
- 2000-03-16 EP EP00921217A patent/EP1169044B1/de not_active Expired - Lifetime
- 2000-03-16 AU AU41557/00A patent/AU4155700A/en not_active Abandoned
- 2000-03-16 AT AT00921217T patent/ATE249227T1/de not_active IP Right Cessation
- 2000-03-16 WO PCT/SE2000/000514 patent/WO2000056343A1/en active IP Right Grant
- 2000-03-16 DE DE60005164T patent/DE60005164D1/de not_active Expired - Lifetime
- 2000-03-16 JP JP2000606247A patent/JP2002539266A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2002539266A (ja) | 2002-11-19 |
SE9901007D0 (sv) | 1999-03-19 |
WO2000056343A1 (en) | 2000-09-28 |
EP1169044B1 (de) | 2003-09-10 |
DE60005164D1 (de) | 2003-10-16 |
AU4155700A (en) | 2000-10-09 |
EP1169044A1 (de) | 2002-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20024011L (no) | Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret | |
Seppala et al. | Triple therapy of Helicobacter pylori infection in peptic ulcer: a 12-month follow-up study of 93 patients | |
BG101118A (en) | Therapeutical compounds | |
CA2460749A1 (en) | Glycoconjugate vaccines for use in immune-compromised populations | |
BR9911076A (pt) | Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica | |
EP2272522A3 (de) | Therapeutische Zusammensetzungen zur Verwendung bei der Prophylaxe oder Behandlung von Diarrhö | |
BR0013814A (pt) | Métodos de tratamentos de um paciente humano suscetìvel a ou diagnosticado com uma doença com anticorpos anti-erbb2, artigos industrializados, métodos de tratamentos de câncer em pacientes humanos e usos do anticorpo anti-erbb2 | |
MXPA05000880A (es) | Probioticos para funciones neuromusculares del intestino. | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
BR0112685A (pt) | Composição nutricional | |
NO20060498L (no) | Metode for a promotere benvekst | |
BR0314511A (pt) | Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater | |
BRPI0016231B8 (pt) | composições compreendendo enzimas úteis para tratar ou melhorar os riscos de infecção do trato digestivo | |
BRPI0410341A (pt) | conjugados de polissacarìdeo-proteìna derivatizados de meningococos multivalente e vacina | |
SE9600716D0 (sv) | Adhesion inhibitors, preparation comprising them and method for producing them | |
MX2008001520A (es) | Composiciones de tizanidina y metodos de tratamiento usando las composiciones. | |
IL173481A0 (en) | Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration | |
BR9808008A (pt) | Processo para o tratamento anticoagulante e/ou antitrombótico de um ser humano ou outro paciente animal de sangue quente, usos de um oligossacarìdeo sulfatado e na fabricação de um medicamento, e, composição farmacêutica ou veterinária para tratamento anticoagulante e/ou antitrombótico. | |
EP1393734A4 (de) | Arzneimittel gegen darmerkrankungen | |
ATE249227T1 (de) | Verwendung von fucosilierten sialilierten n- acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion | |
CA2120062A1 (en) | Use of Sulodexide and of Medicines Containing It in the Treatment of Diabetic Nephropathy | |
SE9904581D0 (sv) | A novel helicobacter pylori-binding substance and use thereof | |
BRPI0410761A (pt) | uso de leucina, e, composição para administração entérica a pacientes | |
BRPI0416088A (pt) | composição, sistema, e método de tratar condições tais como calcificação vascular | |
Robo et al. | HBOT application at cases of gingival inflammation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |